Latest Innovation News

Locate Technologies has completed its redomiciliation from Australia to New Zealand, establishing Locate NZ as the new parent company and appointing MUFG Pension & Market Services as its share registry provider.

Recce Pharmaceuticals has won a significant Australian Government R&D tax incentive, unlocking up to A$85 million for its synthetic anti-infective programs worldwide, including a pivotal Phase 3 clinical trial.

Emyria has secured its first Empax clinic in Victoria, marking a significant step in its multi-state expansion and validating its scalable, reimbursed national mental health platform.

Entropy Neurodynamics has successfully completed dosing the first patient in its TRP-8803 clinical trial for Binge Eating Disorder, marking a key milestone with controlled psychedelic infusion and safety clearance. Top-line results are expected in early 2026.

Immutep Limited reports robust progress in its pivotal Phase III TACTI-004 trial for advanced non-small cell lung cancer, with over 120 clinical sites activated across 27 countries including the US. Patient enrolment has reached 38% of the target, keeping key milestones on track.

Anson Resources and POSCO Holdings have advanced their collaboration on the Green River Direct Lithium Extraction demonstration plant, with POSCO’s investment decision timeline pushed to early 2026. The partnership signals a strategic move to secure North American lithium resources and commercialize cutting-edge extraction technology.

MetalsGrove Mining Limited has been granted the Vavoua gold exploration permit in Côte d’Ivoire, advancing its strategic foothold near the Abujar gold mine. An initial soil sampling program using cutting-edge PortablePPB technology is set to commence early next year.

Lake Resources has disclosed an inadvertent breach of ASX Listing Rule 7.1 related to the timing of share issuance under an agreement with Acuity Capital. The company is taking steps to strengthen governance and prevent future errors.

Acusensus Limited has announced a $30 million equity placement to bolster its balance sheet, alongside winning a landmark $34 million contract in Connecticut, marking a significant step in its US expansion. The company also reported multiple contract expansions in Australia and a new debt facility to support its growth ambitions.

Acusensus Limited has successfully raised $30 million through a placement of 20 million shares at $1.50 each, supported by both existing and new investors. The capital injection aims to fuel business development, product innovation, and operational expansion.

Titomic Limited has landed a $1.7 million Early Manufacturing Development contract with a leading defense prime, aiming to fast-track production of advanced defense components using its proprietary cold spray additive manufacturing technology.

Alexium International has acquired Microtek Laboratories’ microencapsulation and phase-change material business, backed by a $6.8 million entitlement offer to strengthen its manufacturing and innovation capabilities in the US.